TEVA PHARMACEUTICAL INDUSTRIES LIMITED Repayments of Short-term Debt
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) reported Repayments of Short-term Debt of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-03.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfShortTermDebt · last filed 2026-02-03
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED repayments of short-term debt for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED repayments of short-term debt for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED repayments of short-term debt for the quarter ending 2023-12-31 was $500.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED repayments of short-term debt for the quarter ending 2023-09-30 was $200.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED repayments of short-term debt for fiscal 2025 was $0.00.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED repayments of short-term debt for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED repayments of short-term debt for fiscal 2023 was $700.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED repayments of short-term debt for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Repayments of Short-term Debt 3 month | Repayments of Short-term Debt 6 month | Repayments of Short-term Debt 9 month | Repayments of Short-term Debt 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-03 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $0.00 derived: sum of 2 quarters · filed 2026-02-03 | $0.00 10-K · filed 2026-02-03 | |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-06 | $0.00 10-Q · filed 2024-11-06 | ||
| 2023-12-31 | $500.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $700.00M derived: sum of 2 quarters · filed 2026-02-03 | $700.00M 10-K · filed 2026-02-03 | |
| 2023-09-30 | $200.00M 10-Q · filed 2024-11-06 | $200.00M 10-Q · filed 2024-11-06 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-05 | $0.00 derived: sum of 2 quarters · filed 2025-02-05 | $0.00 10-K · filed 2025-02-05 | |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | ||
| 2021-12-31 | $500.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-12 | $700.00M 10-K · filed 2024-02-12 | ||
| 2021-09-30 | $200.00M 10-Q · filed 2022-11-03 | |||
| 2020-12-31 | $443.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $559.00M 10-K · filed 2023-02-10 | ||
| 2020-09-30 | $116.00M 10-Q · filed 2021-10-27 | |||
| 2019-12-31 | $502.00M 10-K · filed 2022-02-09 | |||
| 2018-12-31 | $260.00M 10-K · filed 2021-02-10 |